| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e071d18fea054bf8d1420d483e78ed1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16222 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 |
| filingDate |
1986-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04961e2827a4ad1d754dc8c465311ca1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d870509bb155139171ae4bb1ec9bc85f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43e5b4b6df64566a3d0ce00b2708e74b |
| publicationDate |
1987-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0245459-A1 |
| titleOfInvention |
T CELL LYMPHOTROPHIC VIRUS PROTEIN AND TEST PROCEDURE. |
| abstract |
Cells infected with HTLV-III produce a protein (p27) having an apparent molecular weight of about 27,000 daltons. The presence in biological samples of p27 antigenic determinants, or of antibodies to p27 antigenic determinants represents useful information (in itself or as part of a set of tests) for predicting the evolution of HTLV infection -III in HIV-positive patients. The present invention relates to polypeptides and antibodies used to perform assays to obtain this information, as well as assays and assay kits. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6706268-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5705612-A |
| priorityDate |
1985-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |